Eagle Rock Investment Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Buy
2,725
+25
+0.9% +$25.5K 0.4% 60
2026
Q1
$2.48M Sell
2,700
-250
-8% -$253K 0.36% 65
2025
Q4
$3.17M Sell
2,950
-100
-3% -$95.6K 0.45% 58
2025
Q3
$2.33M Hold
3,050
0.34% 69
2025
Q2
$2.38M Sell
3,050
-186
-6% -$145K 0.38% 69
2025
Q1
$2.67M Sell
3,236
-189
-6% -$157K 0.46% 60
2024
Q4
$2.64M Sell
3,425
-237
-6% -$196K 0.44% 63
2024
Q3
$3.24M Sell
3,662
-2
-0.1% -$1.8K 0.54% 53
2024
Q2
$3.32M Sell
3,664
-94
-3% -$75.2K 0.6% 50
2024
Q1
$2.92M Sell
3,758
-479
-11% -$341K 0.54% 54
2023
Q4
$2.47M Sell
4,237
-750
-15% -$438K 0.51% 57
2023
Q3
$2.68M Sell
4,987
-440
-8% -$227K 0.61% 46
2023
Q2
$2.43M Sell
5,427
-390
-7% -$164K 0.52% 51
2023
Q1
$2M Sell
5,817
-1,623
-22% -$547K 0.46% 58
2022
Q4
$2.68M Sell
7,440
-350
-4% -$124K 0.62% 46
2022
Q3
$2.52M Sell
7,790
-150
-2% -$47.5K 0.66% 48
2022
Q2
$2.57M Sell
7,940
-750
-9% -$225K 0.63% 44
2022
Q1
$2.49M Sell
8,690
-630
-7% -$162K 0.53% 48
2021
Q4
$2.57M Buy
+9,320
New +$2.36M 0.49% 54

Other funds holding LLY

Eagle Rock Investment Company's LLY Position: Q2 2026 in Review

Eagle Rock Investment Company increased its Eli Lilly (LLY) stake by 0.93% in Q2 2026, buying an estimated $25.5K and bringing the position to 2,725 shares worth $3.27M. The position accounts for 0.4% of the portfolio, ranked #60.

Eagle Rock Investment Company first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.32M in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Eagle Rock Investment Company held 2,725 shares of Eli Lilly worth $3.27M as of Q2 2026.
  • Eagle Rock Investment Company bought 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.4% of Eagle Rock Investment Company's portfolio in Q2 2026, its #60 holding.
  • Eagle Rock Investment Company first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • Eagle Rock Investment Company's Eli Lilly position peaked at $3.32M in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Eagle Rock Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.